142 related articles for article (PubMed ID: 2945154)
1. Standardization of monoclonal antibodies for use in autologous bone marrow transplantation for common acute lymphoblastic leukemia.
Bradstock KF; Favaloro EJ; Kabral A; Kerr A; Prendergast M; Berndt MC; Hughes WG; Zola H; Krishnan R; Haylock D
Pathology; 1986 Apr; 18(2):197-205. PubMed ID: 2945154
[TBL] [Abstract][Full Text] [Related]
2. Transplantation of monoclonal antibody-purged autologous bone marrow for treatment of poor risk common acute lymphoblastic leukemia.
Bradstock KF; Stevens M; Bergin M; Dalla-Pozza L; Duval P; Favaloro EJ; Kabral A; Kerr A; Juttner C; Zola H
Aust N Z J Med; 1987 Jun; 17(3):283-9. PubMed ID: 2960307
[TBL] [Abstract][Full Text] [Related]
3. Preclinical studies of a panel of 12 monoclonal antibodies in view of bone marrow purging in acute lymphoblastic leukemia.
Racadot E; Herve P; Lamy B; Peters A
Leuk Res; 1987; 11(11):987-94. PubMed ID: 2961950
[TBL] [Abstract][Full Text] [Related]
4. Autologous bone-marrow transplantation in CALLA-positive acute lymphoblastic leukemia after in-vitro treatment with J5 monoclonal antibody and complement.
Ritz J; Sallan SE; Bast RC; Lipton JM; Clavell LA; Feeney M; Hercend T; Nathan DG; Schlossman SF
Lancet; 1982 Jul; 2(8289):60-3. PubMed ID: 6177990
[TBL] [Abstract][Full Text] [Related]
5. Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging.
Uckun FM; Kersey JH; Haake R; Weisdorf D; Ramsay NK
Blood; 1992 Feb; 79(4):1094-104. PubMed ID: 1531306
[TBL] [Abstract][Full Text] [Related]
6. An immunotoxin for immunologic manipulation of marrow ex vivo in autologous transplantation for common acute lymphoblastic leukemia.
Herrmann R; Pelham J; Meyer B; Davis R; Raphael C; Kraft N; Atkins R
Transplant Proc; 1986 Apr; 18(2):278-80. PubMed ID: 2938314
[No Abstract] [Full Text] [Related]
7. Use of a cocktail of monoclonal antibodies and human complement in selective killing of acute lymphocytic leukemia cells.
Sugita K; Majdic O; Stockinger H; Holter W; Köller U; Peschel C; Knapp W
Int J Cancer; 1986 Mar; 37(3):351-7. PubMed ID: 3456339
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal-antibody-purged autologous bone marrow transplantation for relapsed non-T-cell acute lymphoblastic leukemia in childhood.
Niemeyer CM; Ritz J; Donahue K; Sallan SE
Haematol Blood Transfus; 1987; 31():67-74. PubMed ID: 2965082
[No Abstract] [Full Text] [Related]
9. Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement.
Bast RC; Ritz J; Lipton JM; Feeney M; Sallan SE; Nathan DG; Schlossman SF
Cancer Res; 1983 Mar; 43(3):1389-94. PubMed ID: 6337707
[TBL] [Abstract][Full Text] [Related]
10. Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemia.
Morishima Y; Sao H; Ueda R; Morishita Y; Murase T; Kodera Y; Ohno R; Tahara T; Yoshikawa S; Kato Y
Jpn J Cancer Res; 1985 Dec; 76(12):1222-9. PubMed ID: 3937834
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody-ricin conjugate cytotoxic to cells expressing the common acute lymphoblastic leukemia antigen (CALLA).
Pelham JM; Meyer BF; Herrmann RP; Davis RE; Raphael CL; Kraft N; Atkins RC
Pathology; 1987 Apr; 19(2):124-30. PubMed ID: 2969499
[TBL] [Abstract][Full Text] [Related]
12. Cultured marrow stromal cells express common acute lymphoblastic leukaemia antigen (CALLA): implications for marrow transplantation.
Keating A; Whalen CK; Singer JW
Br J Haematol; 1983 Dec; 55(4):623-8. PubMed ID: 6200132
[TBL] [Abstract][Full Text] [Related]
13. Serological study for in vitro use of monoclonal antibody for autologous bone marrow transplantation in null cell-type acute lymphocytic leukemia.
Sao H; Morishima Y; Ueda R; Yoshikawa S; Kodera Y; Ohno R; Takahashi T
Jpn J Cancer Res; 1985 Dec; 76(12):1212-21. PubMed ID: 3937833
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody 55 (CD10) and complement used for purging autologous bone marrow in common acute lymphoblastic leukemia.
Bai Y; Piao XH; Luo QL; Mao BZ
Chin Med J (Engl); 1990 May; 103(5):385-90. PubMed ID: 2118055
[TBL] [Abstract][Full Text] [Related]
15. Autologous bone marrow transplantation in acute lymphoblastic leukemia--preclinical immunologic studies.
Janossy G; Campana D; Burnett A; Coustan-Smith E; Timms A; Bekassy AN; Hann I; Alcorn MJ; Totterman T; Simonsson B
Leukemia; 1988 Aug; 2(8):485-95. PubMed ID: 3045431
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
Raso V; Ritz J; Basala M; Schlossman SF
Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
[TBL] [Abstract][Full Text] [Related]
17. Bone-marrow purging with monoclonal antibodies and human complement in ALL and AML.
Majdic O; Sugita K; Touw I; Köller U; Stockinger H; Delwel R; Löwenberg B; Knapp W
Haematol Blood Transfus; 1987; 31():86-8. PubMed ID: 3327791
[No Abstract] [Full Text] [Related]
18. Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies.
Quackenbush EJ; Letarte M
J Immunol; 1985 Feb; 134(2):1276-85. PubMed ID: 3155538
[TBL] [Abstract][Full Text] [Related]
19. Vim-2, candidate monoclonal antibody for purging autologous marrow grafts in acute myeloblastic leukaemia.
Delwel R; Bot F; Knapp W; Löwenberg B
Bone Marrow Transplant; 1987 Aug; 2(2):149-54. PubMed ID: 3332163
[TBL] [Abstract][Full Text] [Related]
20. In vitro depletion of clonogenic cells in adult acute lymphoblastic leukemia with a CD10 (anti-cALLA) monoclonal antibody.
Marie JP; Choquet C; Perrot JY; Thevenin D; Pillier C; Boucheix C; Zittoun R
Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1181-7. PubMed ID: 3308484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
